LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents

被引:0
作者
Cynthia Santillan
Kathryn Fowler
Yuko Kono
Victoria Chernyak
机构
[1] University of California San Diego,Liver Imaging Group, Department of Radiology
[2] Washington University,Mallinckrodt Institute of Radiology
[3] University of California San Diego,Department of Medicine, Department of Radiology
[4] Montefiore Medical Center,Department of Radiology
来源
Abdominal Radiology | 2018年 / 43卷
关键词
Hepatocellular carcinoma; Liver; MRI; CT; LI-RADS;
D O I
暂无
中图分类号
学科分类号
摘要
The Liver Imaging Reporting and Data System (LI-RADS) was designed to standardize the interpretation and reporting of observations seen on studies performed in patients at risk for development of hepatocellular carcinoma (HCC). The LI-RADS algorithm guides radiologists through the process of categorizing observations on a spectrum from definitely benign to definitely HCC. Major features are the imaging features used to categorize observations as LI-RADS 3 (intermediate probability of malignancy), LIRADS 4 (probably HCC), and LI-RADS 5 (definite HCC). Major features include arterial phase hyperenhancement, washout appearance, enhancing capsule appearance, size, and threshold growth. Observations that have few major criteria are assigned lower categories than those that have several, with the goal of preserving high specificity for the LR-5 category of Definite HCC. The goal of this paper is to discuss LI-RADS major features, including definitions, rationale for selection as major features, and imaging examples.
引用
收藏
页码:75 / 81
页数:6
相关论文
共 58 条
[1]  
Kono Y(2017)CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI Abdom Radiol 53 1020-1022
[2]  
Chernyak V(2017)LI-RADS Abdom Radiol 266 376-382
[3]  
Bruix J(2011) ancillary features on CT and MRI Hepatology 267 776-786
[4]  
Sherman M(2013)Association for the Study of Liver, Management of hepatocellular carcinoma: an update Radiology 28 747-769
[5]  
American D(2013)New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma Radiology 56 908-943
[6]  
Wald C(2008)Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR images and their value as an imaging biomarker Radiographics 36 264-272
[7]  
Choi JW(2012)Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features J Hepatol 45 1-9
[8]  
Hanna RF(2011)EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma Abdom Imaging 26 267-272
[9]  
Matsui O(2015)Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis Hepatol Res 58 1188-1193
[10]  
Muto J(2016)Review of angiogenesis in hepatocellular carcinoma Sci Rep 81 881-889